A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma

NCT00108953 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin
DRUG: Doxorubicin/Placebo

Sponsor

Bayer